155 related articles for article (PubMed ID: 37673741)
1. ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer.
Wang J; Xiao Y; Li D; Zhang C
Asian J Surg; 2023 Nov; 46(11):5376-5378. PubMed ID: 37673741
[No Abstract] [Full Text] [Related]
2. KRT72 might serves as a prognostic biomarker for patients with prostate cancer.
Wang J; Xiao Y; Yu Q; Zhang C
Asian J Surg; 2023 Nov; 46(11):5382-5384. PubMed ID: 37673738
[No Abstract] [Full Text] [Related]
3. TEX19 could function as a prognostic biomarker for prostate cancer.
Xiao Y; Wang J; Feng D; Zhang C
Asian J Surg; 2023 Dec; 46(12):5671-5673. PubMed ID: 37648546
[No Abstract] [Full Text] [Related]
4. Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.
Lamy PJ; Allory Y; Gauchez AS; Asselain B; Beuzeboc P; de Cremoux P; Fontugne J; Georges A; Hennequin C; Lehmann-Che J; Massard C; Millet I; Murez T; Schlageter MH; Rouvière O; Kassab-Chahmi D; Rozet F; Descotes JL; Rébillard X
Eur Urol Focus; 2018 Dec; 4(6):790-803. PubMed ID: 28753865
[TBL] [Abstract][Full Text] [Related]
5. Hoxb13, a potential prognostic biomarker for prostate cancer.
Ouhtit A; Al-Kindi MN; Kumar PR; Gupta I; Shanmuganathan S; Tamimi Y
Front Biosci (Elite Ed); 2016 Jan; 8(1):40-5. PubMed ID: 26709644
[TBL] [Abstract][Full Text] [Related]
6. An overview of translational prostate cancer cohorts for prognostic and predictive studies.
Tolkach Y; Kristiansen G
Histopathology; 2019 Jan; 74(1):161-170. PubMed ID: 30565297
[TBL] [Abstract][Full Text] [Related]
7. Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis.
Zhao L; Yu N; Guo T; Hou Y; Zeng Z; Yang X; Hu P; Tang X; Wang J; Liu M
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1047-54. PubMed ID: 24636974
[TBL] [Abstract][Full Text] [Related]
8. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
9. PRR7 could serve as a prognostic biomarker for prostate cancer patients.
Guo Y; Yu Q; Ke M; Wang J
Asian J Surg; 2023 Nov; 46(11):5133-5135. PubMed ID: 37422382
[No Abstract] [Full Text] [Related]
10. Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer.
Spratt DE
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):513-515. PubMed ID: 29893267
[No Abstract] [Full Text] [Related]
11. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the detection and prognosis of prostate cancer.
Hernandez J; Canby-Hagino E; Thompson IM
Curr Urol Rep; 2005 May; 6(3):171-6. PubMed ID: 15869720
[TBL] [Abstract][Full Text] [Related]
13. CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.
Bastos DA; Antonarakis ES
Expert Rev Mol Diagn; 2018 Feb; 18(2):155-163. PubMed ID: 29319382
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer SubtyPINg biomarKers and outcome: is clarity emERGing?
Smith SC; Tomlins SA
Clin Cancer Res; 2014 Sep; 20(18):4733-6. PubMed ID: 24944315
[TBL] [Abstract][Full Text] [Related]
15. New biomarkers for diagnosis and prognosis of localized prostate cancer.
Chistiakov DA; Myasoedova VA; Grechko AV; Melnichenko AA; Orekhov AN
Semin Cancer Biol; 2018 Oct; 52(Pt 1):9-16. PubMed ID: 29360504
[TBL] [Abstract][Full Text] [Related]
16. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
[TBL] [Abstract][Full Text] [Related]
17. IL-8 Produced Via Bidirectional Communication Between Prostate Cancer and M2 Macrophages as a Potential Diagnostic and Prognostic Biomarker.
Fan H; Tang Z; Tian Y; Lv Q; Zeng F
Technol Cancer Res Treat; 2023; 22():15330338231177809. PubMed ID: 37226533
[TBL] [Abstract][Full Text] [Related]
18. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
[TBL] [Abstract][Full Text] [Related]
19. TRIM24 as an independent prognostic biomarker for prostate cancer.
Offermann A; Roth D; Hupe MC; Hohensteiner S; Becker F; Joerg V; Carlsson J; Kuempers C; Ribbat-Idel J; Tharun L; Sailer V; Kirfel J; Svensson M; Andren O; Lubczyk V; Kuefer R; Merseburger AS; Perner S
Urol Oncol; 2019 Sep; 37(9):576.e1-576.e10. PubMed ID: 31178279
[TBL] [Abstract][Full Text] [Related]
20. Noncanonical Wnt as a prognostic marker in prostate cancer: "you can't always get what you Wnt".
Fisher RR; Pleskow HM; Bedingfield K; Miyamoto DT
Expert Rev Mol Diagn; 2020 Feb; 20(2):245-254. PubMed ID: 31814454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
